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CONSUMER HEALTH INFORMATICS:
ETHICS, EVALUATION AND STANDARDS
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Abstract: This article discusses the ethical issues involved in consumer health informatics –specifically those issues
surrounding the provision of medical information for patients on the World Wide Web. The discussion includes concerns
and suggestions relating to: quality control and error avoidance, Internet governance and Web site responsibility, and
intellectual property and control. These issues are argued to be of exceptional importance in the developing world,
including Latin America and the Caribbean.
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CONSUMIDOR DE SALUD INFORMÁTICA:
ÉTICA, EVALUACIÓN Y ESTÁNDARES
Resumen: Este artículo discute los temas éticos involucrados en la información en salud, específicamente aquéllos en
torno a la entrega de información médica a los pacientes que ingresen a la World Wide Web. La discusión abarca
preocupaciones y sugerencias en relación con el control de calidad, evitar los errores, el gobierno de Internet, la
responsabilidad del sitio Web y el registro de la propiedad intelectual. Se argumenta que estos temas tienen gran
importancia en el mundo en desarrollo, incluyendo a Latinoamérica y el Caribe.
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O CONSUMIDOR DE SAÚDE INFORMÁTICA: ÉTICA, AVALIAÇÃO E MODELOS
Resumo: Este artigo discute os temas éticos envolvidos na informação em saúde, especificamente no fornecimento de
informação médica aos pacientes que ingressam na World Wide Web. A discussão envolve preocupações e sugestões
em relação ao controle de qualidade, evitar os erros, o governo de Internet, a responsabilidade do site Web e o registro
da propriedade intelectual. Argumenta-se sobre questões e temas de grande importância no mundo em desenvolvimento,
incluindo a América Latina e o Caribe.
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Introduction
Attention to ethical issues in the health
professions has tended to emphasize challenges
related to patient care (e.g., informed or valid
consent), end-of-life controversies (withdrawing
and withholding treatment), access to services
(allocation of resources), special procedures
(organ procurement and transplantation), and so
forth. While new health technologies are
traditionally a locus of ethical importance, often
under these same headings, the growth of
medical or health informatics has begun to
capture the sustained attention of clinicians,
scientists and scholars(1). Consumer health
informatics is an increasingly important aspect
of the computerization of health practice and
communication, and it, too, requires ethical
analysis and scrutiny.
Indeed, the creation, implementation,
maintenance and use of information resources
on the Internet constitute one of the most
extraordinary developments in the history of
health communication. From patient discussion
groups to on-line decision support to health
advice and advocacy on the World Wide Web, it
is clear that digital communication is profoundly
altering patient and provider access to
information and decision support. This has been
true for some time in many countries. The growth
of the Web and its widening global availability
make these issues especially important for
patients, clinicians and policymakers in Latin
America, the Caribbean and elsewhere.
While most debates in bioethics address
direct patient care, most ethical issues related to
the World Wide Web concern the control of
information provided to patients and prospective
patients. A defining characteristic of the Web is
the lack of an overriding governing or quality
management authority controlling either the
content that is provided to consumers or access
to that information. The Internet (a) permits very
broad dissemination not otherwise possible, (b)
provides more-or-less unhindered access to
information (for those who can afford computers
and connection charges) without the intervention
of a medical professional, (c) disseminates
information from sources whose credentials
cannot easily be checked by consumers, and (d)
can provide for consumers’ anonymity so that if
errors are detected and corrections made after
original dissemination there is no guarantee that
the consumer will, or even can, be made aware
of the corrections.
What therefore makes the Web
simultaneously attractive and worrisome is that
anyone with access to a computer and an
Internet connection can “publish” (or “make
public” in an original sense of the term)
anything, and most anyone with computer
access can read it. While some of the resulting
ethical issues are similar to those involving
medical information in other media (e.g.,
newspapers, professional journals and texts,
direct physician-patient communication), most
other means of information dissemination are
usually accompanied by some control over
content, such as independent quality standards
or peer review. Such “control” often amounted,
traditionally, to no more than the difficulty
encountered in obtaining the information since
most printed medical journals were available
only in specialized libraries or by personal
subscription.
This is not the case with the World Wide Web,
and we therefore will focus on ethical issues that
arise when control over information is the central
point of contention: quality control and error
avoidance, Internet governance and Web site
responsibility, and intellectual property and
control. Our goal is to sketch a conceptual lattice
for future analysis, risk assessment, policy
development and best-practice standards,
assuming that such efforts should be driven in part
by ethical considerations. Our focus will be on
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consumer health informatics, defined as a field
“devoted to the development, implementation, and
research on telecommunication and computer
applications designed to be used by consumers to
access information on a wide variety of health
care topics(2)”. However, many of the same issues
apply when health care professionals are the
consumers. We will also address the issue of a
formalized Internet presence, such as a specific
Web site or an Internet support group, rather than
e-mail between individuals (which others have
addressed(3, 4). Similarly, we will not discuss
issues of confidentiality and privacy, which are
tangential to issues of quality and standards, and
which require sustained treatment elsewhere. We
will focus on the ethical obligations of information
providers, rather than consumers.
It should be emphasized that there are a
number of initiatives to develop tools and
guidelines to evaluate the quality of health
information on the Internet(5-7). along with
commentary on these efforts(8, 9). This is
important, and should be viewed as providing
the data and criteria on which ethical analyses
must be based. Significantly, though, a thread
that runs throughout all these efforts is that
current research is inadequate for complete or
comprehensive evaluations of consumer health
informatics tools. As early as 1997 it was noted
that there is a “need to conduct systematic and
rigorous research on the use of informatics tools
at a time when these tools are being developed
without sufficient knowledge about their effects
on patient decision-making, health outcomes,
and related costs(10)”. There is also a need to
incorporate ethical concerns into any review
process. It remains to be seen whether there
ought to be stricter review in the developing
world – on the one hand, we do not want to
stifle innovation; on the other, we perhaps ought
to endorse additional protections for
populations that might be regarded as
vulnerable.
“Progressive Caution”
Bioethics has provided conceptually and
practically useful tools for addressing issues in
patient care, death and dying, access to services,
special procedures and other topics. Bioethics
can similarly guide decisions and actions in
matters related to health informatics. Attempts
to balance the risks and benefits of computer
use in the health professions have confronted
the following challenge: How can we enjoy the
benefits of improved information technology
while minimizing the risks of promotionalism,
unbalanced advocacy and technology
fetishism? Put differently: How does one
ethically optimize practice and procedures in a
context of scientific uncertainty?
One approach, which we regard as
compatible with requirements both to respect
persons and to maximize good consequences,
has been termed “progressive caution(11)”. The
idea is simply that innovation should be
supported and encouraged in an environment
that emphasizes testing, evaluation and at least
a scruple of skepticism in the face of uncritical
enthusiasm. As one of the authors (KWG) has
written: “Medical informatics is, happily, here
to stay, but users and society have extensive
responsibilities to ensure that we use our tools
appropriately. This might cause us to move
more deliberately or slowly than some would
like. Ethically speaking, that is just too
bad(11)”.
The principle of progressive caution seems
applicable in the context of consumer health
informatics as well as other areas in which the
tools of the Information Age are used in the
service of the traditional healing sciences. This
principle underlies the following discussion of
ethical concerns related to consumer health
informatics, with special regard for Latin
America and the Caribbean.
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Risk vs. Quality
One way to determine whether a medical tool
should be used is to ask whether it will improve
patient care. If the answer is affirmative, then
there might be a moral requirement that the tool
be used(12, 13). If the answer is that the tool
increases the risk of harm to patients, then, all
other things being equal, we should disdain,
discourage or prohibit its use. Far more common
in the case of new technologies, though, is broad
uncertainty about the consequences of use.
While we should not regard patient
information media as medical tools or devices
per se, we might suggest that they be judged in
terms similar to those for judging devices. In
fact, the U.S. Food and Drug Administration
(FDA), the federal agency responsible for
regulating medical devices, has for a number
of years been reviewing its policies on medical
software(14). The current policy exempts from
regulation software where there is the
possibility of “competent human intervention”
between the provision of advice or information
and any actions that directly affect a patient. In
the case of most medical software, the physician
is assumed to be competent to determine the
validity of the advice(15). Miller and Gardner
advocate retaining the criterion of competent
intervention, but also recognize that risk to
patients must also be considered in determining
the amount and type of regulation needed(14).
On this basis they would also exempt most
informational and clinical decision-support
software.
It is unlikely, however, that the Internet falls
into the same category as clinical decision
support systems, since there is no guarantee that
patients obtaining advice on the Internet are
competent to evaluate it, or that a physician is
an intermediary. A Web site that displays false
or misleading information, for instance, can
produce or contribute to bad clinical outcomes
when no competent clinician, scientist, or even
adequately educated patient is available to filter
such content. A Web site that intentionally
misleads patients (perhaps by touting a
proprietary device, drug or service) is especially
blameworthy. In both instances (that of
sloppiness and frank deception), patients may
be placed at increased risk.
Evaluation of risk and quality can be
exquisitely difficult. A study of instruments
used to evaluate health information on the
Internet found great variability in the evaluation
criteria and the reliability and validity of the
rating instruments themselves(16). The authors
also questioned whether it was even desirable
to evaluate health information, and argued that
studies of health outcomes must complement
quality ratings.
Many risks are worth running, but this can
be determined only against a background of
information about the level of risk and the
magnitude of potential benefits and harms. The
very foundations of informed or valid consent
for clinical practice and human subjects
research are based on the idea that prospective
patients and subjects must be competent,
uncoerced and adequately informed about risks
and potential benefits. One can run a risk, as
for instance of an untoward side effect of an
experimental drug, and then be harmed, as when
the side effect actually occurs. But whether a
wrong was committed is determined in light of
the adequacy of the consent process: if
information about the risk was not appropriately
disclosed, the subject was wronged. It is also
possible that one runs a risk that is not realized,
but is wronged nonetheless because of the
inadequacy of the consent process(17).
Accuracy, Timeliness and Presentation
Similar insights apply to the question of
Web site accuracy and quality. While improved
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access to health information can (a) help
patients to participate in their treatments and
so can lead to improved outcomes(18), and (b)
“reduce the need for some unnecessary medical
services(19)”, such access also risks inflaming
unrealistic expectations and can, paradoxically,
dissuade some patients from seeking
appropriate medical attention.
Both kinds of consequences may be related
to Web site quality. It remains to be determined
empirically if there is a correlation between high
quality/accuracy and good medical outcomes
on the one hand, and low quality/accuracy and
poor outcomes on the other. There is some
evidence that health professions students, who
presumably have more knowledge than the
ordinary patient, without instruction on quality
filtering are not always adept at filtering the
information on websites for consumers(20). It
is reasonable to insist at the very least on the
following criteria for evaluating Web-based
consumer health information:
• Accuracy: Does the information represent
the best available research on a topic? If
there is uncertainty about a particular
malady, intervention, treatment, etc., is this
uncertainty appropriately disclosed? Does
it apply to the intended patient population?
• Timeliness: Is the information regularly
reviewed and evaluated for accuracy?
• Presentation, formatting and editing: Is the
information presented in such a way as to
minimize misunderstanding?
Each criterion must eventually be linked to
a standard, or a set of public benchmarks. For
instance, what are minimal acceptable levels
of accuracy? How up-to-date must information
be? At what educational level should
information be presented? These criteria are
recommended –and standards should be
developed– for two overarching ethical reasons.
First, “failing to adhere to publicly defensible
standards is to risk or do harm, which, without
some overriding justification or reason, is
unethical(11)”. Second, even in the absence of
harm or the risk of harm, communicators are
duty-bound to regard readers, viewers,
consumers, etc. with appropriate respect and
thus not deceive them, patronize them or
manipulate them. Adding to our earlier
discussion of risks, harms and wrongs, it should
also be clear that one might commit a wrong
even in a risk- and harm-free environment:
deception is often blameworthy even if no other
ill comes of it.
Errors of many sorts are a feature of medical
practice and health communication. This does
not mean that all errors are benign, or that
practitioners have a diminished responsibility for
error avoidance. The challenge for those who
communicate health information on the Internet
is that it is not always clear what should be
counted as an error in the first place. Unlike
clinical practice, which can accommodate
reasoned disagreement about the constitution of
a community standard, the Internet health
community has yet to evolve an overarching
philosophy and associated standards. More or
less clear standards can simultaneously provide
a conceptual foundation for an enterprise and be
the source of productive debate and disagreement
–much the same as a national constitution both
lays down the law of the land and provides a
structure for disagreements about that law.
Suppose, for instance, that a Web site
provides dietary information and guidance for
people with various endocrine disorders, and
that this information is based on current but
often inconclusive data. (The example is
intended to be hypothetical; any similarity to
an actual Web site is unintentional.) Suppose
further that this is an area of ongoing research.
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If a patient alters his or her diet as a result of
consulting the Web site, and has a bad outcome,
does it make sense to say that those responsible
for designing and maintaining the site erred?
What if subsequent research showed that the
initial recommendations were incorrect or
should be superseded by more recent data?
Does it matter if the Web site included a
disclaimer or warning? How robust a disclaimer
is needed if designers acknowledge that
disclaimers are often ignored, or that despite
warnings people –especially sick people– are
grasping for easy fixes and will latch onto any
advice that seems to hold promise? Does a lack
of access to care (in a developing country, for
instance) increase the desperateness of people
to acquire data? The most miserable barrio is
more likely to host an Internet café than a
hospital.
If a physician gives advice to a patient on
Monday and then learns on Thursday of evidence
that he or she was mistaken, it is usually a
straightforward matter to get in touch with the
patient and update, modify or recant the advice.
The physician giving the advice will also have a
sense of the extent to which the patient
understood it. If a patient misunderstands or does
not enjoy a subsequent correction of medical
advice, we often (though not always) may lay
blame at the physician’s feet. Adequate
communication is just part of sound medical
practice. But no such requirement accompanies
Web-based advice. Although some websites
request patient email addresses, ostensibly for
follow-up, there is usually no requirement to
provide such contact information, nor is there
any guarantee that patients would be honest in
the information they provide. Because users are
–indeed, perhaps should be– anonymous, it
makes little sense to suggest that they be
contacted if earlier information is found to be
incorrect. Because there are no agreed upon
standards for measuring comprehension of
medical information by laypeople on the Internet,
it similarly would be unhelpful at present to
suggest that users be electronically queried or
quizzed about their level of understanding.
While we can imagine a Web site that
includes quizzes to measure understanding, or
even a “registration” procedure by which
subscribers would be updated about specific
advice, we cannot assume that these procedures
would provide adequate protection. Such
measures edge so close to what we might
otherwise call the practice of medicine that it
would be inappropriate to adopt them on the
Internet without extensive research. That is to
say, it would be inappropriate to adopt such
measures while passing them off as sound or
credible before soundness or credibility has
been determined. A 1997 report likened the
Internet to a “cocktail conversation rather than
a tool for effective health care communication
and decision making(21)”. Although today
there have certainly been improvement in the
development of effective health communication
websites, the quality remains uneven. For this
reason, health professionals may be in a unique
position to assist patients with evaluating these
sites, but the health professionals themselves
may need instruction about how to evaluate
quality(22).
Disclosures and disclaimers
If errors are an unavoidable part of medical
(or any human) practice, and if the Internet can
be presumed to be similarly fallible, it is
important to consider whether disclosures can
constitute adequate warning to users. That is,
is it ethically adequate to inform Web site
visitors that (1) information might be erroneous,
(2) the user cannot simultaneously enjoy
anonymity and be informed of new data that
bear upon an earlier query, (3) there is no
substitute for competent medical attention, and
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even (4) that the Web site has a commercial
owner or sponsor whose goals include financial
or commercial benefit?
Such disclosures can in principle be quite
useful. Indeed, to maintain a health Web site
without some form of fair warning regarding
accuracy, follow-up, standards of care, and
conflicts of interest is to overlook or forgo
minimal criteria for any sort of professional
health communication. Yet we have no evidence
to show that in electronic contexts such warnings
are or could be taken seriously or have any effect;
this is perhaps especially true in an environment
marked by quick responses, false starts,
abandoned threads. Moreover, we must attend
to the problem of the “computational fallacy” or
“the view that what comes out of a computer is
somehow more valid, accurate, or reliable than
human output(23)”. As long as laypeople and
professionals alike regard information available
from computers and/or the Web as being
inherently superior to that provided by
appropriately trained or expert humans, we risk
severe error. One error source rarely considered
in the context of consumer health informatics
is that search engines that scientists and
consumers use to identify Web sites of interest
or importance are themselves subject to severe
limitations –because the Web is “distributed,
dynamic, and rapidly growing,” search engines
often, if not usually, miss or fail to index some
two-thirds of the “indexable Web(24)”. This is
perhaps especially significant in the context of
calls for “participatory research” and the use by
patients and families of systematic reviews to
assist decision making(25).
We have been discussing the disclosure of
Web site properties and shortcomings. It is
important to note that a disclosure is not the
same as a disclaimer. A disclosure is an
uncovering or making public of certain facts; a
disclaimer is a renunciation of responsibility.
Some Web sites and medical software include
statements that combine elements of both,
though there is an emphasis on the latter, i.e.,
on the renunciation of responsibility and
perhaps even liability. It is not clear what kind
of disclaimer is adequate for legal protection.
What is clear on ethical grounds is that any
Web-based information system intended or
likely to be used by laypeople must at a
minimum include a full and frank disclosure
regarding accuracy, follow-up, standards of
care, and conflicts of interest. These are some
of the criteria that are advocated by Health on
the Net (www.hon.ch) and other organizations
who have taken on the task of evaluating and
certifying Web site quality.
Web Site Governance and Responsibility
The task of error avoidance falls to those
who finance, develop, edit, maintain and tout
Internet health sites. Disclaimers and
disclosures notwithstanding, the act of Web site
governance occurs in the context of an evolving,
albeit inchoate, standard of care.
Perhaps the most important concern to
address is that people with diseases and other
maladies can be especially vulnerable to harm
from on-line medical information. This means
they may be more susceptible to hucksterism
and promotion; more willing to take irrational
risks; and more inclined to harbor false hopes.
These observations point to the two over-
riding ethical obligations of those responsible
for Web site content, namely, the duty to adhere
to, or develop, quality standards, including
standards for accuracy and disclosure; and the
duty to adhere to or develop standards for
protecting vulnerable users. Webmasters must
in general be mindful of the dangers of the
computational fallacy, especially with
vulnerable patients or medically underserved
populations. This obligation has special
applicability to children and minors.
Consumer Health Informatics: Ethics, Evaluation and Standards - E. Berner, A. Singh Sandhu and K. Goodman
140
Web sites differ from books, compact disks
and other media chiefly because they create the
appearance and expectation of accuracy,
immediacy and timeliness. While book authors,
editors and publishers, for instance, have ethical
obligations to be as accurate as possible, no one
can reasonably fault them for a book that has
become out of date, or for a patient who seeks
out the book, misinterprets it, and is harmed.
Health-related Internet sites either are designed
for patients or are more easily available to them
than most medical libraries.
The point here is not to suggest that health-
related Web sites are inherently dangerous, or
to pass judgment on the intentions of those who
create and maintain them. But good intentions
are not a substitute for adherence to quality
standards. The current challenge is that society
is just now developing those standards. As ever,
scientific progress engenders ethical
controversy and conflict. The best way to meet
such challenges is to identify areas of concern
and propose tools for “ethical best practices.”
As with any new technology, the need to
monitor and perhaps revise quality and best-
practice standards might be very great. This
might be difficult, if not onerous, bothersome,
or downright vexing; but these practical
impediments are not ethical challenges.
Protection and paternalism
In arguing that minors, certain patients, some
developing countries and others are, by virtue
of their vulnerability, entitled to special or extra
protection from risk, we invite the objection that
such protections are patronizing or paternalistic.
The objection might take this form: “The Internet
in an open society can provide unfettered access
to a variety of opinions, alternative sources of
information, and diverse professional and quasi-
professional advice. It is demeaning to suggest
that free people should expect any sort of special
treatment or protection.” It might further be
suggested that the sorts of measures commended
here would have a chilling effect on the creation
and development of salutary World Wide Web
resources.
There are a number of responses to such
objections. First, it should be underscored that
we are scrutinizing the dissemination to patients
of medical information and advice –not poultry
recipes, football statistics or travelogues. When
the stakes include public health, it is reasonable
to insist that ethical considerations of minimizing
harm, respecting persons and adhering to sound
quality criteria should guide practice. Second,
professional and trade organizations have not
previously been shy about regulating the actions
of members, be they individual practitioners,
groups or corporations; it is not clear why patient
communication should not be accorded a
commensurate level of attention. Third,
insistence on ethical standards does not constitute
a call for government regulation, legal sanctions
or other measures that might in themselves
warrant objections on grounds of free speech.
One might analogously insist that journalists
explore and adhere to ethical principles without
any sort of suggestion that government should
have a say in newspaper content. There is no
evidence that attention to ethical “best practices”
would have the purported chilling effect.
To be sure, use of any medium for
commercial fraud or other kinds of deception for
profit should invoke at least the consideration of
social control. That the Internet is sometimes
used to “promote and sell fraudulent or illegal
medical products” legitimately raises the
prospect of regulation(26).
Property and control
The question of who owns an electronic
repository or network is among the most
interesting of the Information Age. When
resources are pooled from a collection of
Acta Bioethica  2005; 11 (2)
141
disparate sources (philanthropic, corporate,
academic, governmental) it can be quite difficult
to decide who owns or controls the repository.
We are not here addressing the problem of
intellectual property, which is well studied, but
that of ownership of the means of information
dissemination.
Some ownership issues are easy enough:
Ownership of computers and other hardware
can generally be straightforwardly assigned or
apportioned. Further, there are commonly
acceptable means of assigning property rights
to databases, networks and other entities that
straddle the conceptual divide between
patentable devices and intellectual property.
A somewhat more interesting challenge
arises in trying to determine who or what should
control a consumer health Web site. In one case,
a dispute over Web site control emerged at a
university-based cancer information service. As
the site gained in popularity, averaging 10,000
daily “hits” from around the world, a sequence
of events led to university physician-
administrators taking control of the site from a
non-physician who was a cofounder(27). At
dispute was the question of adequate peer
review, disagreement over information quality,
and, derivatively, the dissemination of health
information under a university’s imprimatur.
One can understand an institution insisting that
health-related Web sites bearing the institutional
logo be under institutional control. Contrarily,
most institutions would clearly exceed their
authority by requiring staff members (identified
as such) to seek committee approval for
scholarly publications or for remarks made to
the news media.
Part of the tension here is that we have yet
to sort out the complexities of peer review for
traditional media, such as books and journals;
it is no wonder that peer review will challenge
us on the World Wide Web.
The ethical challenge in such cases is shaped
by considerations of governance and
responsibility on the one hand, and free
expression on the other. It is ultimately an
empirical matter whether patients face increased
risk as a result of medical Web sites either
controlled by non-physicians or containing
information not “approved” by physicians.
Evidence of such risk would weigh in favor of
some degree of medical oversight, if not
collaboration. We earlier disdained government
control of Web sites; what is the nature of the
difference between government control and
institutional or professional control? Universities
traditionally do not screen faculty members’
publications for accuracy or the risk of danger
to lay readers or consumers. Is the Internet
sufficiently different to warrant such oversight?
As elsewhere in the health professions, ethical
issues here will be illuminated by more and better
data. There is no reason to suppose we should
resolve a problem in practical ethics –any more
than a problem in clinical practice– by a priori
means. This is to argue only that health
professionals and scientists must count the
Internet as among the entities worthy of empirical
and conceptual scrutiny. Put differently, much
more research is required before we can hope
for closure on an ensemble of issues at the nexus
of the Internet, health and ethics.
This demand is of particular importance in
Latin America, the Caribbean and the rest of
the developing world. As countries leap forward
in telecommunications capacity, the need to
assess the effect of these changes acquires a
moral urgency, lest populations accustomed to
traditional forms of exploitation be exploited
in subtle new ways.
Conclusion and Recommendations
It is no small challenge for clinicians to
synthesize and act on the latest evidence-based
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data. It stands to reason that patients also need
some help in trying to make sense of a
bewildering stew of information.
Communicating health information is rarely
a straightforward matter. Physicians and nurses
who talk with their patients about something as
pedestrian as this morning’s newspaper article
on diet or cancer risks know that ignorance, hope
and fear shape behavior and beliefs as often as
evidence, reason and logic.
The World Wide Web has extraordinary promise
as a source of patient information and advice. But
like other new health technologies, we do patients
no favors by touting an untested tool.
For the Web to realize its potential:
1. It must be subjected to increasingly rigorous
tests of accuracy, timeliness and readability;
2. Web sites must eliminate, or minimize and
disclose, actual and potential conflicts of
interest;
3. Entities that sponsor or own Web sites must
recognize their responsibility to attend
simultaneously to quality improvement and
free expression
Medical Web site sponsors and owners who
are motivated mainly by profit, public relations
or prestige should be regarded with the same
disdain we customarily hold for health
professionals who place these values ahead of
patient care. It is not that fair compensation,
positive community regard and respect and
admiration are inappropriate for physicians or
Web site owners but, rather, that we ethically
optimize practice by a more appropriate
ordering of values.
The concept of progressive caution seems
to capture intuitions about how best to balance
the risks and benefits of consumer health
informatics. It remains for scientists and
scholars to make clearer how to enjoy the fruits
of progress while taking care not to succumb
to the hucksters, boosters, bells, and whistles
that experience has taught can come between
people and high quality care. Failure to use the
best of health information technology will be a
loss to the people of Latin America and the
Caribbean. Failure to use this technology
responsibly will allow the entire enterprise to
be seen by some populations as a cruel trick.
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